Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Echinococcus multilocularis | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | fatty acid desaturase, putative | 0.1341 | 1 | 0.5 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0205 | 0.1067 | 0.4004 |
Leishmania major | fatty-acid desaturase, putative | 0.1341 | 1 | 0.5 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 0.2666 | 1 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0128 | 0.0468 | 0.1754 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0205 | 0.1067 | 0.4004 |
Onchocerca volvulus | 0.1341 | 1 | 0.5 | |
Schistosoma mansoni | lipoxygenase | 0.009 | 0.0164 | 0.0843 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.1341 | 1 | 0.5 |
Onchocerca volvulus | 0.1341 | 1 | 0.5 | |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.1341 | 1 | 0.5 |
Echinococcus granulosus | tumor protein p63 | 0.0408 | 0.2666 | 1 |
Plasmodium falciparum | stearoyl-CoA desaturase | 0.1341 | 1 | 0.5 |
Loa Loa (eye worm) | acyl-CoA desaturase | 0.1341 | 1 | 1 |
Plasmodium vivax | stearoyl-CoA desaturase (acyl-CoA desaturase, faty acid desaturase), putative | 0.1341 | 1 | 0.5 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0128 | 0.0468 | 0.1754 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.1341 | 1 | 0.5 |
Leishmania major | stearic acid desaturase, putative | 0.1341 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0316 | 0.1941 | 1 |
Schistosoma mansoni | lipoxygenase | 0.0128 | 0.0468 | 0.2409 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.0596 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 5.6234 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))] | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.